Investor profile
Debiopharm Group has backed 5 European tech companies across 5 funding rounds between 2013 and 2025, joining rounds totalling €36M. Most active in Software and AI. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| StratifAI | Germany | 1 | €13M |
| Mika | Germany | 1 | €10M |
| BC Platforms | Switzerland | 1 | €9.1M |
| Tune Insight | Switzerland | 1 | €3.2M |
| KeyLemon | Switzerland |
| Company | Stage | Amount | Date |
|---|---|---|---|
| StratifAI | Other | €13M | 2025-09 |
| Mika | Other | €10M | 2022-05 |
| BC Platforms | Series B | €9.1M | 2017-05 |
| Tune Insight |
| 1 |
| €1.1M |
| €3.2M |
| 2023-09 |
| KeyLemon | Series A | €1.1M | 2013-09 |
